Stereotactic ablative radiation to metastases slows prostate cancer progression
Patients with oligometastatic prostate cancer treated with stereotactic ablative radiotherapy had longer progression-free survival than observation-only controls
Read article: Stereotactic ablative radiation to metastases slows prostate cancer progression